Biopharmaceutical company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | MADRIGAL PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$380,000 | |
| 2025 | MADRIGAL PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$280,000 | |
| 2025 | MADRIGAL PHARMACEUTICALS, INC. |
3rd Quarter (July 1 - Sep 30) AMENDED |
$30,000 | |
| 2025 | MADRIGAL PHARMACEUTICALS, INC. |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | 4 | $690,000 |